Risk factors for new-onset diabetes after kidney transplantation

被引:58
作者
Sharif, Adnan [1 ]
Baboolal, Keshwar [2 ]
机构
[1] Queen Elizabeth Hosp, Renal Inst Birmingham, Dept Nephrol & Transplantat, Birmingham B15 2TH, W Midlands, England
[2] Univ Wales Hosp, Nephrol & Transplant Unit, Cardiff CF14 4XW, S Glam, Wales
关键词
RENAL-TRANSPLANTATION; INSULIN-RESISTANCE; GLUCOSE-METABOLISM; HEPATITIS-C; CYTOMEGALOVIRUS-INFECTION; CARDIOVASCULAR-DISEASE; CALCINEURIN INHIBITOR; LONG-TERM; MELLITUS; CYCLOSPORINE;
D O I
10.1038/nrneph.2010.66
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
New-onset diabetes after transplantation, a common complication following kidney transplantation, is associated with adverse patient and graft outcomes. Our understanding of the risk factors associated with this metabolic disorder is improving and both transplantation-specific and nonspecific factors are clearly involved. Knowledge of these risk factors is important so that clinicians can implement pre-emptive risk stratification strategies and to guide therapeutic, risk-attenuation approaches in patients who develop transplant-associated hyperglycemia. In this Review, we explore the current understanding of the diverse range of risk factors that contribute to abnormal glucose metabolism after transplantation, with the aim of helping to guide clinical decision-making using appropriate risk stratification.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 88 条
[81]   Fasting Plasma Glucose and Glycosylated Hemoglobin in the Screening for Diabetes Mellitus After Renal Transplantation [J].
Valderhaug, Tone G. ;
Jenssen, Trond ;
Hartmann, Anders ;
Midtvedt, Karsten ;
Holdaas, Hallvard ;
Reisaeter, Anna V. ;
Hjelmesaeth, Joran .
TRANSPLANTATION, 2009, 88 (03) :429-434
[82]   Providing complementary and alternative medicine in primary care: the primary care workers' perspective [J].
van Haselen, RA ;
Reiber, U ;
Nickel, I ;
Jakob, A ;
Fisher, PAG .
COMPLEMENTARY THERAPIES IN MEDICINE, 2004, 12 (01) :6-16
[83]   Posttransplantation Hypomagnesemia and Its Relation with Immunosuppression as Predictors of New-Onset Diabetes after Transplantation [J].
Van Laecke, S. ;
Van Biesen, W. ;
Verbeke, F. ;
De Bacquer, D. ;
Peeters, P. ;
Vanholder, R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (09) :2140-2149
[84]  
VANHOOFF JP, 1999, TRANSPL P, V31, P49
[85]   Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus [J].
Vincenti, F. ;
Friman, S. ;
Scheuermann, E. ;
Rostaing, L. ;
Jenssen, T. ;
Campistol, J. M. ;
Uchida, K. ;
Pescovitz, M. D. ;
Marchetti, P. ;
Tuncer, M. ;
Citterio, F. ;
Wiecek, A. ;
Chadban, S. ;
El-Shahawy, M. ;
Budde, K. ;
Goto, N. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) :1506-1514
[86]   A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy [J].
Woodle, E. Steve ;
First, M. Roy ;
Pirsch, John ;
Shihab, Fuad ;
Gaber, A. Osama ;
Van Veldhuisen, Paul .
ANNALS OF SURGERY, 2008, 248 (04) :564-577
[87]   Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients [J].
Woodward, RS ;
Schnitzler, MA ;
Baty, J ;
Lowell, JA ;
Lopez-Rocafort, L ;
Haider, S ;
Woodworth, TG ;
Brennan, DC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (05) :590-598
[88]   HNF1B-related diabetes triggered by renal transplantation [J].
Zuber, Julien ;
Bellanne-Chantelot, Christine ;
Carette, Claire ;
Canaud, Guillaume ;
Gobrecht, Sandrine ;
Gaha, Khaled ;
Mallet, Vincent ;
Martinez, Frank ;
Thervet, Eric ;
Timsit, Jose ;
Legendre, Christophe ;
Dubois-Laforgue, Daniele .
NATURE REVIEWS NEPHROLOGY, 2009, 5 (08) :480-484